NVO vs. XLV
Compare and contrast key facts about Novo Nordisk A/S (NVO) and Health Care Select Sector SPDR Fund (XLV).
XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVO or XLV.
Correlation
The correlation between NVO and XLV is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
NVO vs. XLV - Performance Comparison
Key characteristics
NVO:
-1.18
XLV:
0.01
NVO:
-1.74
XLV:
0.11
NVO:
0.77
XLV:
1.01
NVO:
-0.82
XLV:
0.01
NVO:
-1.66
XLV:
0.02
NVO:
29.58%
XLV:
5.96%
NVO:
41.60%
XLV:
14.30%
NVO:
-70.96%
XLV:
-39.17%
NVO:
-56.52%
XLV:
-11.56%
Returns By Period
In the year-to-date period, NVO achieves a -26.02% return, which is significantly lower than XLV's 0.26% return. Over the past 10 years, NVO has outperformed XLV with an annualized return of 10.45%, while XLV has yielded a comparatively lower 8.31% annualized return.
NVO
-26.02%
-13.53%
-44.14%
-49.37%
15.98%
10.45%
XLV
0.26%
-5.42%
-7.27%
-0.89%
8.21%
8.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVO vs. XLV — Risk-Adjusted Performance Rank
NVO
XLV
NVO vs. XLV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVO vs. XLV - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 2.58%, more than XLV's 1.70% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 2.58% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
XLV Health Care Select Sector SPDR Fund | 1.70% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.58% | 1.47% | 1.60% | 1.43% | 1.35% |
Drawdowns
NVO vs. XLV - Drawdown Comparison
The maximum NVO drawdown since its inception was -70.96%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for NVO and XLV. For additional features, visit the drawdowns tool.
Volatility
NVO vs. XLV - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 16.91% compared to Health Care Select Sector SPDR Fund (XLV) at 9.12%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.